April 6, 2021

Interview with… Dr. Jim Lalonde, Head of Microbial Business Area at INSCRIPTA

April 6, 2021

Inscripta joins EuropaBio: delivering global biotechnology advances

March 31, 2021

EuropaBio response to the EGE report ‘Ethics of Genome Editing’

March 29, 2021

Abolis joins the EuropaBio 25th Anniversary in 2021

March 25, 2021

EuropaBio Statement – Vaccine production scale up: International collaboration remains the key

March 22, 2021

EuropaBio and P-BIO launch the National Associations Council Summit 2021 – Building on Biotechnology: from vaccines to Economic Growth for Europe

March 15, 2021

Abolis joins EuropaBio: Sustainable Bio-Based Products

March 9, 2021

Catalent joins the EuropaBio 25th Anniversary in 2021

March 5, 2021

Webinar Report: Measuring the Economic Footprint of the Biotechnology Industry in Europe

March 1, 2021

Rare Disease Week 2021 – Interview with Dr. Ravi Rao, Head of Research & Development, Chief Medical Officer at Sobi

March 1, 2021

EuropaBio Celebrates 25 Years of Biotech Innovation with 2021 Anniversary Programme

February 24, 2021

European Health Emergency Preparedness and Response Authority (HERA) Consultation – EuropaBio’s Feedback

February 15, 2021

The Business of Biotechnology: Growing for Europe’s tomorrow

February 12, 2021

EuropaBio and Alexion: RARE Conversations (Take Two) Keeping Rare Disease Patients In The Centre Of Discussion

February 12, 2021

EuropaBio Response to Public Consultation on the Evaluation of Patient Rights in Cross-Border Healthcare

February 4, 2021

EuropaBio draft response to the IIA on European Health Data Space

February 2, 2021

Measuring the economic footprint of the Biotechnology Industry in Europe (WifOR Study)

January 29, 2021

Building a European Health Union

January 28, 2021

European Biotech Associations Letter to the European Commission regarding the ongoing evaluation of the Orphan Medicinal Products Regulation

January 20, 2021

Revision of the EU legislation on medicines for children and rare diseases

December 24, 2020

Joint Statement: Comitology Reform Threatens Innovation

December 20, 2020

EuropaBio Comments on the Draft Delegated Act on Climate-Related Objectives under the Taxonomy Regulation

November 30, 2020

Call for more effective EU regulation of Clinical Trials with Advanced Therapy Medicinal Products consisting of or containing Genetically Modified Organisms

November 25, 2020

An EU IP Action Plan for strong industrial ecosystems

 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe

FOLLOW US HERE


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


facebook
twitter
instagram
linkedin
youtube
 

BIOTECH NEWSLETTER


Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
March 31, 2021

EuropaBio response to the EGE report ‘Ethics of Genome Editing’

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
October 7, 2020

Nobel Prize for Genome Editing Pioneers

Brussels, 7 October 2020: Today, genome editing pioneers Emmanuelle Charpentier and Jennifer A. Doudna have been awarded the Nobel Prize in Chemistry 2020
September 24, 2020

Genome editing FAQ

Genome editing is an advance in biological tools with the potential for a wide range of applications.
August 24, 2020

Genome-Edited Products and Projects: Resources and Examples

This is a non-exhaustive list of over 200 genome-editing or viral vector related products and research projects, drawn from various resources and covering healthcare, industrial and agricultural biotech
May 20, 2020

EuropaBio position on Germline Genome Editing

EuropaBio and its members strongly believe that genome editing will enable the development of many solutions to the grand challenges facing both people and planet. In medicine, genome editing offers the prospect of saving lives and tackling some of the most devastating genetic diseases.
January 20, 2020

What if we used algae to make biofuel?

Adjusting a specific algae gene with genome editing, enabling the algae to be a feedstock for biofuels.
June 25, 2019

Achieving the Potential of Genome Editing: the Perspective of the European Biotech Industry

EuropaBio, the voice of the biotech industry, has developed this paper to bring the latest views from the developers and users of genome editing tools and applications.
May 9, 2019

Open Letter to Member States on the EU Court Ruling on Mutagenesis

Open Letter to Member States on the EU Court Ruling on Mutagenesis.
November 29, 2018

Statement: As EU court ruling risks blocking innovation, the European biotech industry calls for science-based political decision making on genome edited products

As EU court ruling risks blocking innovation, the European biotech industry calls for science-based political decision making on genome edited products.
Become a member